Real-time enrollment status for this metastatic uveal melanoma clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 3:05 AM UTC
| NCT Number | NCT06626516 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Uveal Melanoma |
| Phase | PHASE1 |
| Target Enrollment | 109 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Thomas Jefferson University |
| Last Updated on CT.gov | July 21, 2026 (Jul 21, 2026) |
As of August 30, 2026: Clinical trial NCT06626516 is currently recruiting participants. This phase1 study for metastatic uveal melanoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Thomas Jefferson University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06626516 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06626516 was last updated Jul 21, 2026 (July 21, 2026). HelloStudys verifies this status automatically.